Making medicines differently to bring better drugs faster to the patients who benefit most with ML and data at scale.
South San Francisco, CA
- Tweets 380
- Following 96
- Followers 6,282
- Likes 61
We're thrilled to announce our $400M Series C financing, which will greatly enable us to continue advancing our vision to reshape the discovery and development of transformative medicines by leveraging #machinelearning and biology and chemistry at scale. bwnews.pr/3eL7G7v
4
28
153
We're excited to announce the open sourcing of redun, an expressive, efficient, and easy-to-use workflow framework designed to deal with complex, rapidly evolving scientific workflows spanning multiple data types. Read more here: insitro.medium.com/8b06b707a…
2
29
130
We are excited to announce the closing of our $143 million Series B financing, supporting expansion of our #machinelearning and data generation capabilities to enable advancement of therapies toward the clinic. #ML4Medicines Read more here: bwnews.pr/2yxsoor
1
32
116
We're pleased to share a look into part of our biology discovery platform, CellPaint-POSH, an ML-enabled high-content pooled optical screening system. Our research shows pooled genetic screening w/ cellular imaging can enhance gene function understanding. biorxiv.org/content/10.1101/…
1
23
86
9,714
Congratulations to our Founder & CEO @DaphneKoller for receiving the Allen Newell Award for seminal contributions to machine learning & probabilistic models, the application of these techniques to biology & human health, & for contributions to democratizing education
ACM-AAAI Allen Newell Award recipient @DaphneKoller has been instrumental in using #MachineLearning as a tool to advance biology and medicine. As a co-founder of @coursera, she has also made great contributions to democratizing education: bit.ly/3cNGS2p
9
72
(1/3) insitro is excited to share our paper “EmbedGEM: A Framework to Evaluate the Utility of Embeddings for Genetic Discovery,” focusing on assessing the use of ML-derived embeddings for genetic discovery using heritability & relevance to specific diseases.
1
11
54
18,421
We're thrilled to announce our collaboration with @bmsnews that focuses on the discovery and development of novel therapies for the treatment of #ALS. Read more: bwnews.pr/3e29OoI
2
7
53
insitro welcomes @SerafimBatz as Chief Data Officer. His expertise in ML and computational genomics will accelerate our progress towards our mission of leading the way to better medicines through predictive models that integrate ML and biology at scale. lnkd.in/gjkew_y
2
4
40
Tomorrow, our CEO & founder @DaphneKoller takes the virtual @TechCrunch Disrupt stage as she talks about our mission of transforming pharma R&D through #machinelearning and data at scale. Watch the livestream here: tcrn.ch/2FBrCKv #TCDisrupt
12
35
We’re very proud to share that insitro CEO & Founder @DaphneKoller has been elected to the National Academy of Sciences in recognition of her pioneering contributions to Machine Learning. Congratulations to Daphne and her distinguished peers for this prestigious recognition! #ML
We are thrilled to announce the election of 120 members and 23 international members to the National Academy of Sciences in recognition of their distinguished and continued achievements in original research. bit.ly/3HyRx2u
Congratulations to our new #NASmembers! #NAS160
3
31
6,387
If you missed our CEO and founder @DaphneKoller's talk at @TechCrunch Disrupt yesterday, hear why she says digital biology is the next big technological revolution and how insitro is using it to shift the trajectory of drug discovery. #TCDisrupt techcrunch.com/video/daphne-…
1
2
35
We're excited to announce our acquisition of Haystack Sciences, leveraging their leading-edge DEL technology, and advancing our aim to become a fully integrated drug discovery and development company. Read the release: businesswire.com/news/home/2…
9
32
Our CEO @DaphneKoller spoke with @RuthReader to discuss what's next following our Series B and how #machinelearning could be the key to cracking the code to drug development. Read below! #ML4Medicines
Combining AI and biology could solve drug discovery’s biggest problems f-st.co/rgHMKO3
10
32
We're proud to share that our CEO and founder @DaphneKoller is the recipient of this year's #IEECS Women of ENIAC Computer Pioneer Award. Congratulations, Daphne! 🎉
Congrats to Daphne Koller and her achievement of the 2022 #IEEECS Women of ENIAC Computer Pioneer Award for “contributions to representation, inference, and learning in probabilistic models with applications to computational biology and human health.” bit.ly/3BMRfB1
1
28
We presented at the virtual #EASL20 conference, sharing findings from our study with @GileadSciences and other university partners which utilized #machinelearning to populate imaging data that quantified the histological features of NASH. View it here: bit.ly/3bnvHNY
10
28
We're thrilled to announce our collaboration with @GenomicsEngland to bring our #MachineLearning-powered embedding search capabilities to their multimodal phenotypic and genetic database to create better medicines for patients in need. businesswire.com/news/home/2…
1
3
24
Thank you to @a16z for hosting yesterday’s AI Revolution event. During their fireside chat, insitro CEO & founder @DaphneKoller & a16z's @vijaypande discussed how AI/ML combined with high-quality datasets could provide novel therapeutic insights & transform drug discovery.
1
27
2,165
We’re excited to share @matthewherper’s new story in @statnews, which spotlights 3 new research papers posted online describing exciting developments emerging from our #ML platform across our core therapeutic areas. Read more below. #JPM24
Biotech founded by Daphne Koller makes stir on eve of JPM conference with new papers on drugs for cancer, ALS, liver disease; poaches new CMO from Pfizer. trib.al/lKUkjRB
10
24
22,508
Big news today! insitro has appointed industry-leading scientist & drug hunter Philip Tagari as CSO. We’re very excited for Philip to partner with our founder & CEO @DaphneKoller and our world-class team as we transform drug discovery & development. bwnews.pr/3gRAazO
2
2
24
We’re excited to hear insitro senior ML engineer and computational chemist @mmsltn present at @AACR’s virtual special conference on #AI, diagnosis and imaging today. To register for the event, visit: aacr.org/meeting/artificial-…
3
22
We're excited to hear our CEO and founder @DaphneKoller deliver the keynote address at #ICML21 today and share our exciting new work in molecular design. To learn more, visit: icml.cc/Conferences/2021/Sch…
1
1
22
Today our CEO and founder @DaphneKoller will keynote #BMVC2021 and Hervé will Spotlight at #MLCB2021. They will share new data suggesting #MachineLearning enables longitudinal phenotyping in live cells. Stream: bmvc2021-virtualconference.c…
7
20
Our CEO and founder @DaphneKoller spoke with @ldtimmerman for The Long Run podcast this week, discussing her journey to tackling #machinelearning for drug discovery. Listen below! ⬇️
Listen to @DaphneKoller @insitro discuss machine learning for drug discovery on The Long Run. timmermanreport.com/2020/10/…
1
6
21
We’re 5,000 followers strong! Thanks for joining us as we journey to transform #drugdiscovery through #machinelearning and data at scale to more efficiently get new medicines to patients in need.
2
19
2,690
Congrats to outstanding insitrocyte, Rachel Groth, who's been recognized @GVteam's Impact List 2021, featuring 25 incredible women shaping the future. Way to go, Rachel! gv.com/impact/
3
20
As a leading company at the intersection of #machinelearning and data generation at scale, we are looking forward to welcoming the Haystack team and working together to create the next-generation therapeutics discovery platform.
7
21
1/7 As published today in AJHG, insitro is excited to share new research in gene-based rare-variant association testing to detect genes with *allelic series*, which helps accelerate efforts to discover new medicines for the patients who can benefit most. cell.com/ajhg/fulltext/S0002…
1
8
20
6,831
Attending #ICML2023? Here are two fantastic opportunities to connect with insitro. First, on Sunday, don't miss the 5th Symposium on Advances in Approximate Bayesian Inference (AABI), co-located at ICML and co-sponsored by insitro. #AABI approximateinference.org/ind…
1
2
17
6,620
Our CEO and founder @DaphneKoller joined fellow visionaries and leaders at the @wef Davos 2024 Annual Meeting this week, discussing the expanding universe of generative #AI models. Watch the full panel below. #WEF24
.@DaphneKoller discusses building computers that are capable of finding patterns to address societal problems in a way that people can’t do on their own. #wef24
1
5
18
2,264
#AI in drug discovery has incredible potential, but it remains hard and some of the hype may not be grounded in reality. Our CEO and founder @DaphneKoller spoke with @MaxGelman about why she believes the industry needs to calibrate people's expectations with what's possible.
Despite a flood of companies entering the AI space, the field has little hard data to show for itself, at least as far as the public can see. And that begs the question: How much of the “AI revolution” is hype, and how much is grounded in reality?
endpts.com/biopharma-has-hyp…
3
3
17
We’re excited to hear insitro CEO & founder, @DaphneKoller share her perspective with entrepreneurs at @StartupGrind. She will discuss how recent advancements in #ML represent new opportunities to solve critical challenges in drug discovery & development. startupgrind.tech/conference…
4
15
11,959
We are excited to welcome @martha_rook, @Tkaraletsos, Ellen Berg and Jevan Soo Lenox to our team! Learn more about how their collective expertise will make an impact at insitro here: businesswire.com/news/home/2…
17
Check out our Founder & CEO @DaphneKoller in a recent interview with Lex Fridman that combines machine learning and biomedicine piped.video/watch?v=xlMTWfkQ… and her appearance in the May/June issue of @Divinaction magazine mydigitalpublication.com/pub…
4
18
Check it out! Our founder and CEO @DaphneKoller joined The Data Pulse podcast to talk about building a culture for data-first drug discovery. Listen below. ⬇️
I had a blast chatting with @DaphneKoller of @insitro about the importance of building a “bilingual” culture when innovating at the intersection of data science + biomedicine. Listen to our conversation to hear insights from this trailblazer! linktr.ee/thedatapulse
3
17
Exciting coverage of our founder & CEO @DaphneKoller and our work at @insitro in the latest issue of @forbes
Check out the full piece below.
forbes.com/sites/jilliandonf… #ML4Medicines #insitro
5
13
Thanks to @TwoSigmaVC for featuring insitro at their AI conference in NYC this week. In a chat with @DusanPerovic, our CEO @DaphneKoller shared how we use ML & data at scale to advance our mission to bring better drugs faster to patients who can benefit most. #AI #ML
1
3
16
2,187
Great to have our Founder & CEO @DaphneKoller
at the #STATsummit on hype vs. reality of AI in Pharma R&D and Pharma’s evolution into a data science with Aviv Regev, Hal Barron, and @DamianGarde
#insitro #ML4Medicines
1
15
We're delighted to welcome Dr. Roger Perlmutter, President of Merck Research Labs, to our board. His extensive experience and deep knowledge of biopharma R&D will be invaluable as we begin building our internal therapeutics pipeline. Read more: bwnews.pr/3io2S5Y
1
6
17
We're thrilled to launch a new insitro.com, an immersive portal into our platform, pipeline, science, technology & culture – the intersection of which makes us a company like no other! Check out our teaser video & bookmark us to follow our science, news & progress.
1
4
16
21,321
Founder and CEO @DaphneKoller welcomed @BiotechTVHQ’s @bradloncar to insitro and gave an inside look at how we are building a different kind of drug company through the power of #machinelearning and data at scale. Check out the full interview below.
Bright Minds: As biotech gravitates to machine learning and AI, @insitro founder @DaphneKoller shares her experience of working this way since 2018.
Full video: biotechtv.com/post/insitro-d…
2
16
1,611
insitro is excited to launch the new and improved insitro.com, bringing you greater insight into our mission, our people, and our approach to transforming #drugdiscovery. #ML4Medicines #MachineLearning
1
16
"Our lives begin to end the day we become silent about things that matter.” -MLK
At @insitro we believe that we must all stand up against injustice, racism and violence. Read the message below by our CEO @DaphneKoller on how we can #changethetrajectory. linkedin.com/posts/insitro_a…
4
16
Congrats to our CEO and founder @DaphneKoller for making @Forbes list of 8 women leading the field of #AI and shaping it for future generations!
Thanks @_RobToews for including me in your @Forbes article and letting me talk about our work about our work at @insitro on using #ML for drug discovery. Honored to be included with a group of such amazing women scientists.
bit.ly/3qU1DBa
2
15
insitro is proud to be on the #XB100 list of 100 private deep tech companies who are commercializing scientific research into deep technology to make a significant impact on the world. Thank you to @BessemerVP & @XPRIZE for the honor. bvp.com/xb100?name=insitro#x…
1
2
12
2,548
Thanks to the AWS team for featuring Matt Rasmussen
(@mattrasmus), our VP Software Engineering, in today's HPC blog. We are grateful for the opportunity to continue sharing our excitement about the redun workflow engine we open sourced last year.
I have always enjoyed my conversations with the smart folks at @insitro. In this post, @mattrasmus talks about their data science workflows that run on AWS Batch. aws.amazon.com/blogs/hpc/dat…
6
13
Congratulations to our amazing CFO/CBO @mmrozenman for being a part of the #20under40 list!
“Mary is like a force of nature: You do not want to get in her way, but she does it in the nicest way,” @DaphneKoller on Mary Rozenman @insitro. “You find yourself doing what she wants, and you think it was your idea.” endpts.com/the-20-under-40-i… #20under40
2
15
Thank you to @JohnCendpts and the team at @endpts for including insitro in the #eleven20 list! We are honored to be included, along with some of the other most promising private companies in biotech as we work to transform drug discovery and development.
Hats off to Endpoints 11 winner @insitro. "The early days were very challenging, I won’t lie," CEO Daphne Koller said. "I won’t say it was easy, but the important things in life are never easy," she added later. #eleven20
endpts.com/the-endpoints-11-…
1
14
Participating in #NeurIPS2022? Join insitro senior machine learning scientist Srinivasan Sivanandan’s virtual presentation tomorrow for a deep dive on using #MachineLearning to analyze and learn from image-based pooled CRISPR knock-out screens.
3
14
Are you looking to push the boundaries? Come join us as we leverage #machinelearning and #AI to create more predictive insights and new medicines through biology and chemistry data at scale. Check out these openings and others below! insitro.com/careers
3
12
Thanks to @AmerChemSociety for featuring insitro scientist Madeleine Kieffer's talk on our DEL-ML Platform at #ACS2023. Integrating insitro’s DNA-Encoded Libraries with our advanced #ML is helping accelerate our drug discovery & development efforts with chemical data at scale.
1
14
2,801
No, it's not opposite day at insitro! It's the G&A and Executive Leadership automation tour courtesy of our amazing process engineering team! Thank you to our PE and imaging #MachineLearning colleagues for giving us a peek into the new labs coming online later this year.
2
13
New insitro research published by @AmerChemSociety introduces DEL-Compose. Our model uses synthons to efficiently represent billions of DNA-encoded library (DEL) molecules, overcoming modeling challenges to enhance prediction & accelerate drug discovery. pubs.acs.org/doi/10.1021/acs…
1
4
14
2,614
Happy anniversary, insitro! We are grateful for our investors, partners and, most importantly, our employees who have been with us every step of the way on our journey to transform drug discovery. 🎉
3
14
For 5 years, we've been making medicines differently & building our industry-leading #ML platform. We were proud to share our latest progress last week during #JPM24. Read our recent news and publications at insitro.com/publications-pre… & stay tuned for more updates during the year.
1
8
13
2,338
Passionate about #machinelearning & human health? At insitro, we're pioneering the use of ML and data at scale to accelerate the drug discovery & development process. Join us in working to transform medicine for patients in need: insitro.com/careers. #AI #ML
2
13
1,426
insitro CEO & founder @DaphneKoller will present at the J.P. Morgan Healthcare Conference on Monday, Jan. 9, at 9 am PT in the Golden Gate Ballroom at Westin St. Francis in SF. Join us for the latest from our journey to transform drug discovery & development with #ML. #JPM2023
3
13
2,169
We’re proud to sponsor today’s 2022 Machine Learning for Health workshop NeurIPS 2022. At insitro, ML fuels our cross-functional approach to accelerating the discovery & development of new medicines for patients. Learn how to join our team at insitro.com/careers #ML4H
1
12
Heading to #SciPy2023? Make sure to check out insitro’s Head of Computational Biology, Angela Pisco, for the Thursday keynote! She’ll be discussing how we can leverage vast biomedical datasets to provide insights for the development of better medicines. scipy2023.scipy.org/.
5
12
3,415
Don't miss insitro scientist Max Salick’s Keystone Symposia presentation on Feb. 7. Max will explain how several technologies – including iPSCs, gene editing, & insitro's advanced genetic screening platform – led to promising new drug discovery targets. bit.ly/3wLbsFx
11
1,519
Congrats to @NEJM for launching NEJM-AI, focused on clinical evidence at the intersection of science, health & AI. We're proud that insitro CEO & founder @DaphneKoller is among the experts on NEJM-AI's editorial board. We can't wait to read the first, trailblazing issue!
Coming soon: NEJM AI, a new journal from NEJM Group.
NEJM AI aims to identify and evaluate state-of-the-art applications of artificial intelligence to clinical medicine. Learn more about the new journal: ai.nejm.org/
2
12
5,132
We are thrilled to announce that Matt Rasmussen has joined insitro as Vice President of Data Engineering and Duane Valz has joined as General Counsel. Welcome, @mattrasmus and Duane! #insitro #ML4Medicine businesswire.com/news/home/2…
1
12
insitro is transforming #drugdiscovery. “We use machine learning to build a compass that, when you hit these intersection points, can tell us which paths to pursue,” said insitro CEO & founder @DaphneKoller in a @Forbes conversation with Steve @vassallo. bitly.ws/wcKg
1
2
12
Our Founder & CEO @DaphneKoller will speak at #WiDS2020 at @Stanford on March 2, a one-day tech conference where you will learn how women in leading-edge organizations leverage data science for success. Register for WiDS Stanford: widsconference.org @WiDS_Conference
9
We're excited to be presenting at the @NeurIPS 2021 AI for Science workshop today. We'll share how our graph neural network (GNN) regression model better identifies diverse, novel molecular binders to challenging targets. Check it out: ai4sciencecommunity.github.i…
1
11
Our CEO and founder @DaphneKoller joined the @AIHealthPodcast to describe insitro's approach to rethinking drug discovery using #machinelearning and data at scale, and the broader trend of digital biology. Listen below! ⬇️
Our latest episode is with @DaphneKoller, CEO and Founder of @insitro, a machine-learning enabled drug discovery company.
Dr. Koller speaks about how insitro uses AI and induced pluripotent stem cells to make drug discovery more efficient and successful.
theaihealthpodcast.com/episo…
1
5
12
Thank you, @AWS, for hosting our Founder & CEO @DaphneKoller to discuss the amazing work here at insitro transforming drug development @AWSreInvent2019 #insitro #ML4Medicines
piped.video/watch?v=BCcujAcb…
12
New Research Alert: insitro is using machine learning to better understand the complexities of cancer. Read our recently published paper to learn about how we leverage ML & patient data to identify novel biomarkers & inform therapeutic interventions. medrxiv.org/content/10.1101/…
2
10
1,046
We’re excited to present oncology research at #AACR23! Join us at the 4/18 poster session to learn about the potential of histopathology #ML embeddings to enable scalable imputation of molecular readouts that are prognostic of clinical outcomes. abstractsonline.com/pp8/#!/1…
2
10
2,496
We are excited to announce the assembly of our Scientific Advisory Board, who will partner closely with our team to help drive our technology and drug development programs forward. Read more: businesswire.com/news/home/2…
1
2
12
Pleased to contribute to EMBL-EBI's precision medicine workshop, where insitro ML scientist Chris Probert shared how insitro’s ML models use high-content molecular data to predict patient outcomes & identify disease drivers. To join our mission: insitro.com/careers
1
3
12
2,082
Thank you @BusinessInsider and @rtnarch for including us! We're on a mission to create better medicines through predictive models, created by #MachinelLearning and biology at scale, and are proud of the great work we are doing for the future of patients.
9 top Bay Area biotechs that VCs say are poised to take off in the next year businessinsider.com/list-top…
1
12
insitro is proud to be part of the @Forbes 2023 AI 50 list! We're honored to be recognized for our use of #AI and #ML to transform drug discovery & development during this pivotal time for the space. Join us in congratulating our team of insitrocytes! forbes.com/companies/insitro…
2
11
5,662
It's go time! #inVivoWeek2023 officially started today at insitro with an incredible, inspiring fireside chat between trailblazing healthcare leader @SueDHellmann and our Founder & CEO @DaphneKoller. Brace yourself for a week of learning, collaboration & boundless #innovation!
3
12
16,651
insitro is honored for CEO & founder @DaphneKoller to speak to early-career scientists at NIH's Junior Investigators Atlas Builders Meeting, Friday, 11 am ET, NYC & virtually. We're inspired by Daphne's enduring commitment to mentoring junior scientists. events.cancer.gov/nci/junior…
2
11
1,269
Thank you to parents, staff & leaders from @tscalliance for joining us to share experiences as caregivers & advocates for people living with tuberous sclerosis complex. We're inspired by your courage & commitment to advancing research for #TSC patients. tscalliance.org
4
12
1,617
Our community of cross-discipline collaborators is transforming drug discovery, and we are proud of the dedication, ingenuity and teamwork that insitrocytes display every day. Hear a few members of the team reflect on their 2022 favorite moments. #HappyHolidays
1
9
2,049
Pleased to be part of @tscalliance’s 2023 Int'l TSC Research Conference. Today, insitro senior director of neuroscience Jordi Serrats presents the poster "Machine Learning Driven TSC Disease Modeling & Reversion Screening in an iPSC Derived Disease Model." tscalliance.org/event/2023-i…
2
10
1,187
Congrats to insitrocytes Kirill Shmilovich, Benson Chen, @Tkaraletsos & @mmsltn for the publication of their recent paper in The Journal of Chemical Information and Modeling! Read about insitro’s progress in modeling DNA-encoded library (DEL) datasets: pubs.acs.org/doi/full/10.102…
1
11
13,132
Join insitro CEO & Founder @DaphneKoller tomorrow for a virtual keynote hosted by @_odsc. Daphne will discuss insitro’s journey to bring better drugs faster to the patients who can benefit most, through machine learning & data at scale. Learn more: odsc.com/boston #AI #ML
1
2
10
1,717
#AI brings new opportunities to decode biology to discover & develop medicines for patients in need. Hear insitro CEO & founder @DaphneKoller and @vijaypande discuss how insitro is leveraging machine learning to transform drug discovery on the latest Bio Eats World podcast.
This week on Bio Eats World, @vijaypande dives deep with @daphnekoller of @insitro into the last few decades of progress in AI, and how she thinks about leveraging AI to drive new insights in biology.
Check it out. 👇 bio-eats-world.simplecast.co…
10
1,383
Join us today as our CEO and founder @DaphneKoller presents at the 40th Annual J.P. Morgan Healthcare Conference at 8:30 a.m. PT / 11:30 a.m. We look forward to sharing our vision for the future of drug discovery and development through #MachineLearning and data at scale.
9
Our CEO and founder @DaphneKoller joined other industry leaders for the #ForbesHealth Summit, talking about the role of #machinelearning in healthcare and how higher quality data sets can significantly improve our understanding of disease biology. Thanks for having us, @Forbes!
1
10
110 insitrocytes strong. Are you team member 111? We are hiring across all departments at insitro and are actively looking for innovative leaders to join our team. insitro.com/careers
9
insitro is excited to host @SF_WomenInBio's discussion “AI, AI, and AI – Revolutionizing Healthcare” on Aug. 24, 5:30 pm PT. Moderated by @drAOPisco, the panel will explore #AI in drug discovery, design & development. #womeninbio Learn more & register: womeninbio.org/event/SanFran…
1
3
10
2,155
Congrats to insitro Founder & CEO @DaphneKoller for being named to @Forbes' 50 Over 50, a recognition of women making an impact on the world. Her leadership motivates us every day as we work together to transform drug discovery to benefit people everywhere.bit.ly/3RL12hg
Introducing The 50 Over 50 2022: Women Stepping Into Their Power In Life’s Second Half trib.al/Hrg0iCX #ForbesOver50 @KnowYourValue
9
We’re thrilled to welcome Dr. S. Michael Rothenberg as insitro’s CMO. With 2 decades of clinical care & drug development experience, his innovations in data-driven trial design will be critical as we advance our pipeline toward the clinic. businesswire.com/news/home/2…
3
11
11,543
Excitement is in the air as we prepare to welcome insitrocytes for our 2nd annual insitro in vivo Week – a week of learning, sharing & innovation. This dynamic event brings insitro colleagues from around the world to collaborate & build together, starting Monday! #invivoweek2023
insitro is on a cross-discipline journey to transform drug discovery. At our 1st "in vivo week," our spirit of learning together showed what makes us special: our culture & colleagues. Celebrate the power of community with us & learn how to join ours at insitro.com/careers
1
9
1,912
Congratulations to our CEO and founder @DaphneKoller for being elected to @statnews' inaugural STATUS list, which recognizes 46 well-known changemakers in the life sciences industry. Check out the full list below! ⬇️
It’s time to meet the STATUS List!
The most definitive accounting of leaders and influencers in the life sciences
See this year’s honorees: buff.ly/3p5pSNg
#STATUSlist
1
9
insitro CEO & founder @DaphneKoller is on the road to speak at key events in the UK and Italy. Catch her at London Tech Week tomorrow and at a Pezcoller Symposium on 6/19 to hear the how #ML and #AI are transforming drug discovery and development. #LTW2023 #Pezcoller23
2
10
1,273
Congrats to our founder & CEO @DaphneKoller, 2022 Technical Leadership Abie Award recipient! Elevating women & non-binary technologists is a role we all play. At insitro, Daphne’s visionary & inclusive leadership fosters a culture of respect where excellence thrives. #GHC22
1
3
10
Catch insitro CEO & founder @DaphneKoller at @broadinstitute Machine Learning in Drug Discovery Symposium tomorrow. In her keynote, Daphne will discuss how insitro uses #ML & data at scale to identify novel drug targets across multiple therapeutic areas. broadinstitute.org/machine-l…
1
10
957
If you're looking for an exceptional team full of smart, collaborative and fun-loving leaders pushing the boundaries of drug discovery, check out our openings! insitro.com/careers
1
8
At insitro, our cross-disciplinary team pushes the boundaries of science and technology every day to transform #drugdiscovery. Join us in using #MachineLearning and data at scale to more efficiently identify and develop treatments for patients in need. insitro.com/careers
2
9
1,710
Congrats to our CFO/CBO @mnrozenman for making @businessinsider's 30 under 40 list of healthcare leaders changing the industry! Mary is an integral part of our team and we're excited to see her hard work recognized. Check out BI's profile on Mary here: bit.ly/3jmrwoU
1
1
8
In the latest #BehindTheTech podcast, our founder and CEO @DaphneKoller spoke with @Microsoft CTO @Kevin_Scott about the emergence of digital biology and how our cutting edge work is transforming drug development. Take a listen here: apple.co/32tGJ01
On the latest #BehindTheTech podcast, I talk with one of TIME Magazine's 100 most influential people, @DaphneKoller. Learn about digital biology, and how her company, @insitro, is making headway in how we treat diseases.
2
9
Join us in welcoming our fellow insitrocyte, Philip Tagari! #CSO
One of the most rewarding aspects of building insitro is our amazing team. I'm thrilled to welcome Philip Tagari, who joins as our inaugural chief scientific officer after serving as a research leader & drug hunter at Amgen for 24 years. Welcome, Philip! tinyurl.com/4crwhyew
2
8
2,033
(3/3) Congrats to @SMukherjee89, @zrmccaw, @JingwenPei, @amerkoul, @raghav_gt, @twsoare, David Amar, @somineniHK, @christophtklein, Santhosh Satapati, @davidjlloydphd, @chrisprobert, @DaphneKoller, @codushlaine & @TKaraletsos. Read our new preprint here: biorxiv.org/content/10.1101/…
4
9
1,162
Our CFO/CBO @mmrozenman will be taking the virtual stage at @Xconomy's Xcelerating Life Sciences San Francisco event on Wednesday. Check it out below!
2
9